Unlikely to cause harm — often a labeling or packaging issue.
Cross Contamination with Other Products
| Brand name | NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS) |
| Generic name | NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS) |
| Active ingredient(s) | NITROFURANTOIN, NITROFURANTOIN MONOHYDRATE |
| Distributed by / for | Sandoz Inc. Princeton, NJ 08540 |
| NDC | 0185-0122-01 |
| Full product label | Nitrofurantoin Capsules, USP (Monohydrate/Macrocrystals) 100 mg, packaged in a) 100-capsule bottles (NDC 0185-0122-01); and b) 1000-capsule bottles, (NDC 0185-0122-10); Rx Only, Distributed by Sandoz Inc. Princeton, NJ 08540 |
| Recalling firm | Sandoz Inc |
| Distribution | Nationwide within the United States |
| Quantity | 14366 bottles |
| Recall initiated | 2018-11-02 |
| Report date | 2018-11-21 |
| Recall completed | 2020-10-02 |
| Recall number | D-0257-2019 |
| Classification | Class III |
| FDA status | Terminated |
| Origin on file | Princeton NJ United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗